SubHero Banner

Khapzory (levoleucovorin) – New Drug Approval

October 23, 2018 - Spectrum announced the FDA approval of Khapzory (levoleucovorin) injection for rescue after high-dose methotrexate therapy in patients with osteosarcoma, diminishing the toxicity associated with overdosage of folic acid antagonists or impaired methotrexate elimination, and for the treatment of patients with metastatic colorectal cancer in combination with fluorouracil.

Download PDF